Le Large, T. Y. S.
Bijlsma, M. F.
El Hassouni, B.
Mantini, G.
Lagerweij, T.
Henneman, A. A.
Funel, N.
Kok, B.
Pham, T. V.
de Haas, R.
Morelli, L.
Knol, J. C.
Piersma, S. R.
Kazemier, G.
van Laarhoven, H. W. M.
Giovannetti, E. http://orcid.org/0000-0002-7565-7504
Jimenez, C. R.
Funding for this research was provided by:
Bennink Foundation
Cancer center Amsterdam
KWF Kankerbestrijding (10212)
Associazione Italiana di Oncologia Medica
Koninklijke Nederlandse Akademie van Wetenschappen (91116017)
Article History
Received: 30 October 2020
Accepted: 24 February 2021
First Online: 9 March 2021
Declarations
:
: Ethical approval for mouse study was contained from the local ethical animal committee.
: All the authors give their consent to publish.
: MB acted as a consultant to Servier. This party was not involved in drafting this manuscript or the study design.HvL has an advisory role at BMS, Lilly, MSD, Nordic Pharma, Bayer and Servier.HvL received research funding from Bayer, BMS, Lilly, Nordic Pharma and Servier. None of these parties were involved in drafting this manuscript or involved with study design.